BrightSpring Health Services Reports Strong Q4 & FY25 Results, Issues Positive FY26 Guidance

summarizeSummary

BrightSpring Health Services reported strong fourth quarter and full year 2025 financial results, showcasing significant revenue and profit growth, a substantial increase in operating cash flow, and improved leverage, alongside positive guidance for 2026.

check_boxKey Events

• Strong Q4 and Full Year 2025 Results

  Reported a 29.3% increase in Q4 net revenue to $3.55 billion and a 28.2% increase in full year net revenue to $12.91 billion. Adjusted EBITDA grew 40.7% in Q4 and 34.2% for the full year.

• Significant Profitability Turnaround

  Achieved a net income of $49.6 million in Q4 and $104.8 million for the full year 2025, reversing a net loss of $68.9 million in 2024.

• Substantial Operating Cash Flow & Improved Leverage

  Operating cash flow for 2025 surged to $490 million, a significant increase from $24 million in 2024. The company also reduced its leverage ratio to 2.99x.

• Positive Full Year 2026 Guidance

  Provided guidance for 2026 revenues of $14.45 billion to $15.00 billion (11.9% to 16.2% growth) and Adjusted EBITDA of $760 million to $790 million (23.1% to 27.9% growth).

auto_awesomeAnalysis

BrightSpring Health Services delivered robust financial performance for both the fourth quarter and full year 2025, marked by significant revenue and Adjusted EBITDA growth. Notably, the company achieved a substantial turnaround from a net loss in 2024 to a net income of $104.8 million for the full year 2025, alongside a massive increase in operating cash flow. The improved leverage ratio further strengthens its financial position. The positive full-year 2026 guidance, projecting continued strong growth in revenue and Adjusted EBITDA, indicates management's confidence in the company's operational trajectory. The share repurchase also signals a commitment to shareholder value. These results are likely to reinforce investor confidence, especially as the stock trades near its 52-week high.